Events

Lorraine Marchand

Innovation Strategist | Board Director | Life Sciences Growth Architect

Lorraine Marchand brings an innovative yet pragmatic mindset shaped by decades of executive leadership in life sciences, healthcare and emerging technologies. With experience in P&L ownership, M&A, clinical development and digital product innovation, she has helped companies navigate market complexity and unlock longterm growth. Lorraine serves on private boards and advisory committees, with a focus on translating science and technology into commercial and shareholder value. She has led the human resources and compensation committees and advised on healthcare M&A.

Lorraine’s executive background spans global roles at IBM Watson Health, Bristol Myers Squibb, IQVIA, LabCorp and Cognizant, where she led businesses up to $350M in revenue. She’s built and exited startups in diagnostics and pharma services, designed and launched innovative product platforms, and overseen more than 250 clinical programs from pre-clinical through global launch.  

She serves on the board of directors of SeromyX Systems; served on the board of Morood Capital, Saudi Arabia; and is on the advisory boards of Ocean Genomics, Extern, Praava Health (Bangladesh) and Science&. She provides trusted counsel on innovation and product pipelines; scaling, transformation, customer-centric business models and M&A readiness.

Author of The Innovation Mindset (Columbia University Press,2022; Axiom Gold Medal Winner), she has served on the faculty of Columbia University, Princeton University, the Wharton School and Moravian University. She holds MBAs from Columbia Business School and London Business School, an M.S. from the American University and a B.S. from the University of Maryland.